Dexcom G7
The CGM-based service will begin in Q4.
The company said it plans to launch the latest model of its CGM in early 2023.
The company also unveiled its 2021 revenue.
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
The executives also share details about what patients can expect from the G7 next year.
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
Dexcom CEO Kevin Sayer has seen the company through some boom years, including growth that has outpaced the company's manufacturing capabilities. But they've learned lessons and are pressing on with a new, smaller sensor in 2021.